Tempus Provider vs IOTOX Algorithm

The Tempus mobile app gives oncology providers fast and reliable access to patient reports, advanced patient search, and real-time order tracking. View interactive and in-depth patient results with: - Next-generation sequencing results including genomic variants and immunotherapy markers - Sortable and filterable clinical decision support tools including treatment implications and clinical trial(s) matched to patient's clinical and molecular profile - Comprehensive gene descriptions paired with matched therapies - Quick access to your patient’s structured clinical timeline - PDF of your full Tempus report all within the app - Access your patient's data quickly and securely with Touch ID or Face ID - Instantly know when a new report is available via push notifications - Check the status of an order from receipt of specimens through sequencing and report delivery

Immunotherapies have become essential in treating advanced malignancies. However, immunotherapies can attack healthy cells, leading to toxicities or side effects. To address how to best treat patients with these toxicities, the Internal Medicine division has collaborated with the Cancer Medicine division, as well as other divisions at MD Anderson, to create the Immuno-Oncology Toxicity (IOTOX) Leaders Group. ​​​​​​​ Clinical management algorithms depict best practices for evaluating, diagnosing, and treating specific conditions that arise during the course of cancer treatment. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.